Excelsior Sciences, which spun out of investment firm Deerfield Management, has roped in $95 million to scale its chemical synthesis “smart bloccs” platform, invest in its internal pipeline and forge partnerships across the industry, including in therapeutics and materials science.
Excelsior collects $95M on mission to accelerate discovery, production of small molecules
Latest from Blog
STAT+: A new rule to prevent the spread of bioweapons
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Hello and happy Monday! We’ve got a lot in store for you today —
COVID Vaccines Produced A Powerhouse Return On Investment, Study Argues
MONDAY, Nov. 9, 2026 COVID-19 vaccines were costly to develop and distribute during the pandemic, but they proved a very worthwhile investment, a new study repo Post Views: 2
Using AI At Work Might Undermine The Boss’ Trust In You, Study Warns
MONDAY, Nov. 9, 2026 There might be a price to your career for using AI at work, even if the tools lead to better productivity, a new study says.Employees who r Post
Radon Linked To Heart Failure Risk In Aging Women
MONDAY, Nov. 9, 2026 Radon gas is already known to cause cancer, but a new study suggests it may also affect heart health.Older women appear to have a higher ri Post Views:
Liver experts finally agree on what acute-on-chronic liver failure is
Liver doctors from around the world have come to agree on a definition for a common and potentially fatal liver complication. Acute-on-chronic liver failure is what happens when someone with underlying liver